About Intelesens

The Complete Electrode Expert & Partner

From Concept to Commercial

Innovators with a vision to improve healthcare delivery

Intelesens began operations in 2000, in Belfast, Northern Ireland. The business comprises of a full production facility, an R&D department and logistics centre. The Company has an established track record with blue chip multinationals as well as small boutique companies, with products sold worldwide.

Core Expertise

Medical sensor industry-based technology
Manufacturing, design and development of
- Defibrillation pads
- ECG, EMG, Screen printed electrodes
- Vital sign sensors

Key Capabilities

End to End product design & manufacture
Material design and selection
Screen printing electrode manufacturing
Ink & Electrode electrical characterisation
ECG testing
Packaging and lamination

Quality and Compliance Standards

Complying to ISO 13485:2016 Quality Management System

Our History

Professor John Anderson headed the effort to produce the world’s first mobile defibrillator to bring the expertise of hospital defibrillator products to the patient in the community and so improve outcomes.

In 2000, Professor Anderson partnered with Professor Jim McLaughlin and Professor Eric McAdams, both accomplished medical engineers, who jointly founded Sensor Technologies and Devices, later to become Intelesens Ltd.

With its continued links into a number of world-leading research institutes, Intelesens has unique know-how in the field of electrode design and development and an established product pipeline of new medtech innovations.

In August 2017, Renew Health Ltd acquired the Intelesens business, and its portfolio of intelligent, wearable, non-invasive, vital signs monitoring devices for the hospital and home patient monitoring markets as well as its electrode design and manufacturing expertise.

In 2019, due to significant demand, the Intelesens production capacity underwent an extensive expansion programme, increasing manufacturing and ensuring consistent supply of electrodes to its established and new partners.